top
Please input keywords
OK
ニュース&PR
お問い合わせ
JP
CN
EN
KR
About us
会社情報
私たちの歩み
管理スタッフ
企業文化
社会的責任
共に働く
研究提携
Antibody Assets
Project Integrum
Antibody discovery platforms
Pipeline
Clinical pipeline
Preclinical pipeline
RenMice
RenMab
RenLite
RenNano
動物・細胞モデル
Humanized animal models
KO mouse models
Tool mice
Immunodeficient mice/rats
Cell lines
Aged mice
Disease mouse models
Pharmacology service
Therapeutic area
Types of services
Molecule type
Technology
ゲノム編集
By species
By technologies
By strategies
Animal Breeding
Animal Cryopreservation
Animal Rederivation
Other Services
Microbial detection
Animal Breeding
Animal Cryopreservation
Animal Rederivation
IR
Stock Information
Financial Reports
Listing Documents
Announcements & Notices
Corporate Governance
Investor Calendar
Email Alert
IR Contact
Home
動物・細胞モデル
動物・細胞モデル
Immunodeficient Mice/Rats
Immunodeficient (B-NDG) Mice
動物・細胞モデル
Humanized Mouse Models
Immune-checkpoint Humanized Mice
Cytokine Humanized Mice
GPCR humanized mice
Other humanized mice
Immunodeficient Mice/Rats
Immunodeficient (B-NDG) Mice
Other immunodeficient Mice/Rats
KO Mouse Models
Drug Target Knockout Mice
Other Knockout Mice
Disease Mouse Models
Tool Mice
Cre Mouse/Rat Models
Reporter Mouse/Rat Models
Other tool mice
Aged Mice
Aged-mouse
Tumor cell lines
Humanized cell lines
Mouse derived cell lines
Reporter cell lines
Other Cell Lines
疾患モデル
Oncology
Allograft Model
Xenograft Model
Spontaneous Tumor Model
Metabolism
NASH Mouse Model Induced by Western Diet(WD)
NASH (Non-alcoholic Steatohepatitis) mouse model
Introduction of Nonalcoholic Steatohepatitis (NASH) Model
Type II Diabetes Models
Autoimmune Diseases
IBD Model
AD Model
DTH Mouse Model
Psoriasis Mouse Model
Asthma Model
EAE model
RA/CIA Mouse Model
Immunodeficient (B-NDG) Mice
Product No
Product
Application area
110586
B-NDG mice
Immune reconstitution, CDX, transplantation, drug evaluation
110586
B-NDG mice-PDX
Immune reconstitution, CDX, transplantation, drug evaluation
110587
B-NDG nude mice
Human immune system reconstitution
110601
B-NDG B2m KO mice plus
Reduce PBMC reconstitution GVHD response and prolong experimental window
110600
B-NDG hIL15 mice
Promote human NK cell differentiation
110599
B-NDG HLA-A2.1 mice
Vaccine study
110596
B-NDG hIL6 mice
Promotes human monocyte differentiation
110590
B-NDG hTHPO mice
Without irradiation, it reduces the damage caused by irradiation to mice
110604
B-NDG hSIRPA mice
Maintain progenitor capacity
120612
B-NDG hIL7/hIL15 mice
Promote differentiation of human T cells and NK cells
110603
B-NDG hSIRPA/hCD47 mice
Evaluation of pharmacodynamic and toxicity of CD47, SIRPA targeted drugs
120609
B-NDG hCSF1/hTHPO mice
Promote differentiation of human myeloid cells without irradiation
113801
B-NDG hTHPO/hSCF mice
110591
B-NDG hCSF1 mice
112869
B-NDG Flt3 KO mice
This product results in a high level of immune system reconstitution after the transplantation of hematopoietic stem cells, especially for DC cells.
112889
B-NDG hFLT3LG, Flt3 KO mice
113385
B-NDG hIL2 mice
112863
huHSC-B-NDG hCSF1/hTHPO mice
112484
huPBMC-B-NDG B2m KO mice plus
112474
B-NDG hB2M/HLA-A11.1 mice plus
112590
B-NDG Tg(RORγt-Il2rg) mice
112914
B-NDG Kit W41 mice
112874
B-NDG hB2M/HLA-A24.2 mice plus
112873
B-NDG hB2M/HLA-A3.1 mice plus
112774
B-NDG hALB/hFcRn mice
112864
huHSC-B-NDG hIL6 mice
Promote differentiation of human monocyte-macrophage
112480
huHSC-B-NDG hTHPO mice
Irradiation is not required to avoid damage to mice caused by irradiation
112479
huHSC-B-NDG MGMT3 mice
Promote differentiation of human myeloid cells;Irradiation is not required to avoid damage to mice caused by irradiation
112865
huHSC-B-NDG HLA-A2.1 mice
To verify the efficacy of HLA-A2.1 restricted vaccines;Promote the development of human CD8+ T cells
112451
B-NDG hB2M/HLA-A11.1 mice
To verify the efficacy of HLA-A11.1 restricted vaccines and antibody-based therapies;Promote the development of human CD8+ T cells
112560
B-NDG hB2M/HLA-A24.2 mice
To verify the efficacy of HLA-A24.2 restricted vaccines and antibody-based therapies;Promote the development of human CD8+ T cells
112450
B-NDG hB2M/HLA-A3.1 mice
To verify the efficacy of HLA-A3.1 restricted vaccines and antibody-based therapies;Promote the development of human CD8+ T cells
112256
B-NDG H2-K1/H2-D1 KO mice
No MHC class I molecule expression; Reduce GVHD and prolong the experimental window period; Improve the accuracy of efficacy verification
111982
B-NDG hALB mice
Used for pharmacological or pharmacokinetic studies of drugs that utilize albumin to extend their half-life
112653
B-NDG hIL15, FcγR KO mice
Promote differentiation of human NK cells;No mouse Fc receptor function
112478
huHSC-B-NDG hIL15 mice
Promote differentiation of human NK cells
112482
huNK-B-NDG hIL15 mice
Promote differentiation of human NK cells
112449
B-NDG hB2M/HLA-A2.1 mice plus
To verify the efficacy of HLA-A2.1 restricted vaccines and antibody-based therapies;Promote the development of human CD8+ T cells
112470
huHSC-B-NDG mice
Human immune system reconstitution, mainly T cells and B cells;reconstitutionl Human-derived cell or tissue engraftmentl Tumor research;Human disease model studyl Efficacy and toxicity verification for
112469
huPBMC-B-NDG mice
Human T cell reconstitution;Human-derived cell or tissue engraftment;Tumor researchl Human disease model study;Efficacy and toxicity verification for human targeted drugs
110593
B-NDG hGM-CSF mice
Promote differentiation of human myeloid cells;For mating with other humanized mice that promote myeloid cell differentiation to obtain multi-humanized mice
110598
B-NDG hairless mice
Hairless, easy to measure tumor
110597
B-NDG hIL7 mice
Promote differentiation of human lymphoid cells
110595
B-NDG H2-Ab1 KO mice
No MHC class II molecule expression; Reduce GVHD and prolong the experimental window period;Improve the accuracy of efficacy verification
111882
B-NDG MGMT3 mice
Promote differentiation of human myeloid cells;Irradiation is not required to avoid damage to mice caused by irradiatio
111895
B-NDG MHC I/II DKO mice plus
No MHC class I/II molecule expression;Reduce GVHD and prolong the experimental window period;Improve the accuracy of efficacy verification
111922
B-NDG hFcRn mice
PK (NDG background can reduce ADA)
111856
B-NDG B2m plus/hIL15 mice
Human immune system reconstitution
110605
B-NDG Hc mice
Antibody CDC function study
Product No
Product
Application area
No Data
バイオサイトジェンの本社は北京市にあり、江蘇省海門、アメリカのボストン、上海に子会社を保有しております。 総従業員数は約1200人で、100%子会社であるEucure Biopharmaを通じて臨床開発を遂行しています。 詳しくは下記のリンクをクリックして何でもお問い合わせください。
お問い合わせ